Beyond the Hype: The Business of Psychedelics 2.0

Date TBA

Depending on whose advice you take, investing in psychedelics might be the best or worst decision you’ll make. While the internet is awash in click bait promoting the latest celebrity promoting psychedelics, sophisticated investors are doing their homework and discovering under-the-radar opportunities before writing checks. Public or private market investing? Biotech /drug development or services businesses? Psilocybin, Ketamine, or new chemical entities ? Join some of the leading founders from the private sector and thought leaders from the space, as they share their thoughts on where the business of psychedelics is headed, what to look out for, and how to steer clear of the pitfalls.

Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.

Myriam Barthes

Journey Clinical, Inc

Daniel Goldberg

Palo Santo VC Fund

Imran Khan

UC Berkeley Center for the Science of Psychedelics

This event will be in person

Details

Primary Entry:
Music Badge
Platinum Badge
Interactive Badge
Film & TV Badge
Format:

Panel

Type:

Session

Track:

Psychedelics

Level:

Intermediate